ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

This publication has 312 references indexed in Scilit:

• Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation
  American Heart Journal, 2005
• Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)
  American Heart Journal, 2005
• Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction
  American Heart Journal, 2004
• Left atrial appendage “stunning” after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography
  American Heart Journal, 1995
• Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled study
  American Heart Journal, 1995
• Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: An analysis of pooled trials
  American Heart Journal, 1995
• Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)
  The American Journal of Cardiology, 1994
• A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs
  The Journal of Clinical Pharmacology, 1984
• Cardioversion of atrial fibrillation: Consideration of embolization, anticoagulation, prophylactic pacemaker, and long-term success
  American Heart Journal, 1982
• Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge
  American Heart Journal, 1959